Back to Search Start Over

Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network.

Authors :
Samuel N
Wilson G
Id Said B
Pan A
Deblois G
Fischer NW
Alexandrova R
Casallo G
Paton T
Lupien M
Gariepy J
Merico D
Hudson TJ
Malkin D
Source :
Oncotarget [Oncotarget] 2016 Aug 02; Vol. 7 (31), pp. 49611-49622.
Publication Year :
2016

Abstract

microRNA-34A is a critical component of the p53 network and expression of miR- 34A is down-regulated by promoter hypermethylation or focal deletions in numerous human cancers. Although miR-34A deregulation may be an important driver in cancer, the endogenous role of this microRNA in cellular homeostasis is not well characterized. To address this knowledge gap, we aimed to determine the transcriptional landscape of the miR-34A-p53 axis in non-transformed cells. Using primary skin-derived fibroblast cell lines from patients who developed childhood cancers, and who harbor either germline TP53 mutations or are TP53 wild type, we sought to characterize the transcriptional response to miR-34A modulation. Through transcriptome-wide RNA-Sequencing, we show for the first time that in human non- transformed cells harboring TP53 mutations, miR-34A functions in a noncanonical manner to influence noncoding RNA networks, including RNA components of the minor (U12) spliceosome, as well as TP53-dependent and independent epigenetic pathways. miR- 34A-regulated transcripts include known cell cycle mediators and abrogation of miR-34A leads to a TP53-dependent increase in the fraction of cells in G2/M. Collectively, these results provide a framework for understanding the endogenous role of the miR-34A signaling axis and identify novel transcripts and pathways regulated by the essential miR-34A-p53 tumor suppressor network.<br />Competing Interests: The authors have declared that no conflicts of interest exists.

Details

Language :
English
ISSN :
1949-2553
Volume :
7
Issue :
31
Database :
MEDLINE
Journal :
Oncotarget
Publication Type :
Academic Journal
Accession number :
27391063
Full Text :
https://doi.org/10.18632/oncotarget.10417